Skip to content

Once-daily combined abacavir/3TC pill available in the UK on a named patient basis

Protein discovered that blocks HIV in monkeys: potential for vaccine and treatment research

Expensive micronutrient formula associated with CD4 increases

HIV attachment inhibitors: three more join the ranks at CROI

Vaccine research: back to the drawing board?

FTC has potent anti-HBV effect in HIV/HBV coinfected patients, and rate of resistance low

Confusion continues at CROI over triple nuke therapy (amended)

Opportunities and challenges on the route to effective microbicides

Gilead abandons research on salvage drug